Creating lung cancer risk models for specific populations refines prediction

September 08, 2008

M. D. Anderson-led team develops first-ever for African-Americans, expands previous model

HOUSTON - Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research.

In the first study to focus on African-Americans, researchers found unique results based on increased exposure to certain risks. Based upon these findings, a specific model was developed to further refine the predictability of lung cancer in this population, according to lead author Carol Etzel, Ph.D., assistant professor in M. D. Anderson's Department of Epidemiology.

"African-Americans have similar risk factors for lung cancer as Caucasians, but the risks tend to be higher, and there is a stronger association with occupational exposures, such as wood dust and asbestos, than we have previously observed for whites," said Etzel. "Additionally, we determined the risks associated with Chronic Obstructive Pulmonary Disease (COPD) are substantially higher than those noted in Caucasian subjects." COPDs, such as emphysema, raise a person's risk for lung cancer.

The study focused on those who self-reported as being black, and who represented approximately 14 percent of the overall study population. Study participants were recruited from M. D. Anderson Cancer Center and the Michael E. DeBakey VA Medical Center in Houston, TX. The control population, which was matched on the basis of age, sex and ethnicity, was recruited from Houston-area community centers and the Kelsey-Seybold Clinic, Houston's largest multi-specialty physician group practice. The African-American model was validated on an independent sample of African-American lung cancer cases and controls from two lung cancer studies being conducted in metropolitan Detroit.

"The challenge for us is to try to predict which of the United States' estimated 45 million current smokers and 46 million former smokers are at highest risk for developing lung cancer. Accurate prediction models may identify subgroups of these smokers who will benefit most from intensive screening programs and behavioral interventions," said Margaret Spitz, M.D., senior author and professor in M. D. Anderson's Department of Epidemiology.

The previously published Spitz lung cancer risk prediction model was based solely on lung cancer cases and controls among Caucasian subjects. Internal and external validation results showed the predictive power of the new African-American group-specific model to approach 79 percent, versus 66 percent for the original model.

"The predictive abilities are much improved with the new model and underscore the need for further race-specific modeling," said Spitz.

Expanding the Original Model

In the second paper, Spitz, the lead author, demonstrates that the predictive capability of her original model which incorporates clinical and risk factor data, was improved by adding two measures of DNA repair capacity.

The original Spitz model measured the following smoking intensity variables: Pack-years of smoking for current smokers and the age at which former smokers stopped smoking, physician-diagnosis of hay fever and emphysema, exposure to asbestos and dusts, and family history of cancer.

Suboptimal DNA repair capacity is associated with up to twofold statistically significant increased lung cancer risks. By adding these measures of repair capacity into expanded former smokers and current smokers models' equations, the sensitivity of each were statistically significantly better than the baseline models. However, the sensitivity of these expanded models remains modest and further refining is planned by incorporating data on nutrition and common genetic variation into even more sophisticated models.

According to the authors, "While the uniform advice for any smoker is immediate cessation, reliable prediction models could be helpful in the context of both screening and prevention trials."

The data for both studies were derived from a long-term 17-year study of the epidemiology of lung cancer at M. D. Anderson funded by the National Cancer Institute and led by Spitz. This research was supported by grants from the National Cancer Institute, and the Flight Attendant Medical Research Institute.

Participants of both studies were defined as "never smokers," or those who had smoked fewer than 100 cigarettes in their lifetimes; "former smokers," who had not smoked in more than a year; and "current smokers," which included individuals who had quit smoking within the past 12 months. Smokers were also asked to report their use of mentholated cigarettes, and former smokers the age at which they stopped smoking.

Lung Cancer Facts

Over 85 percent of all lung cancers occur in current or former smokers. Lung cancer causes more deaths than any other cancer, killing more than 160,000 Americans annually and millions worldwide. According to the American Cancer Society, the incidence of lung cancer is close to 40 percent higher in African-American men, the death rate approximately 30 percent higher and the five-year survival rate is 12 percent versus 15 percent for whites.

Spitz added, "The team is working on a similar model targeting the Hispanic population. Our goal is to ultimately develop an interactive risk assessment tool, much like the Gail breast cancer risk assessment tool, to make lung cancer prediction in various populations accessible for treating physicians."

University of Texas M. D. Anderson Cancer Center

---

---

	Medifocus Guidebook on: Small Cell Lung Cancer by Medifocus.com (Author), Elliot Jacob PhD. (Editor) The MediFocus Guidebook on Small Cell Lung Cancer is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Small Cell Lung Cancer, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Small Cell Lung Cancer, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts,...
	100 Questions and Answers about Lung Cancer (100 Questions & Answers about) by Karen Parles (Author), Joan H. Schiller (Author), Amy Cipau (Author) This book deals with lung cancer from a doctor's perspective and a patient's perspective.
	Be A Survivor: Lung Cancer Treatment Guide by Vladimir Lange MD (Author) This much needed lung cancer resource is developed in consultation with a large national team of experts featuring: * Candid testimonials by survivors * Straightforward, easy-to-understand language * Objective and up-to-date information * Beautiful color photos and graphics * An empowering message of HOPE. The book addresses each step in the diagnosis, staging, treatment and recovery process, and includes a chapter on end-of-life issues, and a section specifically for the patient's partner or caregiver.
	Johns Hopkins Patients' Guide to Lung Cancer by Justin F. Klamerus (Author), Julie R. Brahmer (Author), David S Ettinger (Author) Johns Hopkins Patients' Guide to Lung Cancer is a concise, easy-to-follow how to guide that puts you on the path to wellness by explaining lung cancer treatment from start to finish. It guides you through the overwhelming maze of treatment decisions, simplifies the complicated schedule that lies ahead, and performs the task of putting together your plan of care in layman's terms. Empower yourself with accurate, understandable information that will give you the ability to confidently participate in the decision making about your care and treatment.
	Lung Cancer: A Guide to Diagnosis and Treatment by Walter J. Scott MD (Author) What is my prognosis? What are my treatment options? Which therapies would be the most effective for my stage of lung cancer? These and other frequently asked questions are addressed in this crucial reference designed to help patients educate themselves and obtain the best possible treatments. The completely revised second edition has been updated to include a discussion of the movement towards customized chemotherapy; treatment options for early-stage lung cancer including minimally invasive surgery; and the most promising treatments, among them multimodality therapy—a combination of surgery, chemotherapy, and radiation. Dr. Scott also surveys tests for early detection of lung cancer, talks about the importance of cancer staging, examines alternative treatments, and offers advice on...
	Lung Cancer: Myths, Facts, Choices--and Hope by Claudia I. Henschke (Author), Peggy McCarthy (Author), Sarah Wernick (Contributor) An authoritative book with new lifesaving strategies for those at risk and those already diagnosed.Lung cancer kills more women than breast cancer, more men than prostate cancer. This authoritative book presents new lifesaving strategies for those already diagnosed and those at risk (including ex-smokers). Lung cancer is deadly because it's usually found late. Dr. Claudia Henschke's groundbreaking research on early diagnosis, published in Lancet, made headlines worldwide. Now, for the first time, she offers specific recommendations based on her latest findings: who needs to be checked and how to get tested. People with lung cancer often are told, "Nothing can be done." Not so! Dr. Henschke and coauthor Peggy McCarthy, a leading patient advocate, provide...
	Principles and Practice of Lung Cancer: The Official Reference Text of the International Association for the Study of Lung Cancer (IASLC) (Pass, Lung Cancer) by Harvey I. Pass (Editor), David P. Carbone (Editor), David H. Johnson (Editor), John D. Minna (Editor), Giorgio V. Scagliotti (Editor), Andrew T. Turrisi (Editor) Thoroughly revised and updated, this Fourth Edition is the most comprehensive, current reference on lung cancer, with contributions from the world's foremost surgeons, radiation oncologists, medical oncologists, pulmonologists, and basic scientists. Coverage includes complete information on combined modality treatments for small cell and non-small cell lung cancer and on complications of treatment and management of metastases. Emphasis is also given to early detection, screening, prevention, and new imaging techniques. This edition has expanded thoracic oncology chapters including thymus, mesothelioma, and mediastinal tumors, more detailed discussion of targeted agents, and state-of-the-art information on newer techniques in radiotherapy. Other highlights include more international...
	American Cancer Society Complete Guide to Nutrition for Cancer Survivors: Eating Well, Staying Well During and After Cancer by Abby S. Bloch PhD RD (Editor), Barbara Grant MS RD CSO LD (Editor), Kathryn K. Hamilton MA RD CDN CSO (Editor), Cynthia A. Thomson PhD RD (Editor) Written for consumers, patients, and families seeking reliable information about nutritional support for people with cancer, this comprehensive guide offers the latest information about using nutrition to optimal advantage during the cancer journey. Also discussed is the role of sound nutritional choices before, during, and after cancer therapy and how they can help bolster energy levels, strengthen the immune system, fight off infection, and minimize the side effects of treatment. Charts, information on special diets, and level-headed advice about dietary supplements make this a valuable tool for maintaining a healthy lifestyle.
	BILLION DOLLAR LUNGS Asbestos, Mesothelioma, Cancer and your rights to cash by Boca Press LLC Mesothelioma and Asbestos victims learn about rights to money & million dollar cash awards, dealing with life prolonging treatments, and how to make the legal system work.
	The Doctor Who Cures Cancer by William Kelley Eidem (Author) Don't you wish that cancer treatments could be pain free? And that you'd get well and be cancer free? For instance, do you know which supplements shrink tumors and which ones make tumors grow faster? You can find out which is which in Chapter 33. Dr. Revici even makes the bones eaten away by cancer grow back. Yes, bones eaten away by cancer return to normal on x-rays. This is the true story of a physician who found himself in trouble for curing his patients of cancer and inventing a new kind of chemotherapy that works without making you sick. Yes, this is a true story....and it's a story that could melt away your fear of cancer.